[HTML][HTML] Cellular senescence in cardiovascular diseases: a systematic review
C Hu, X Zhang, T Teng, ZG Ma, QZ Tang - Aging and disease, 2022 - ncbi.nlm.nih.gov
… cells) in age-related cardiovascular diseases. Then, we highlight the targets (SIRT1 and
mTOR) that regulating cellular senescence in cardiovascular disorders. Furthermore, we review …
mTOR) that regulating cellular senescence in cardiovascular disorders. Furthermore, we review …
The role of cellular senescence in cardiac disease: basic biology and clinical relevance
M Mehdizadeh, M Aguilar, E Thorin… - Nature Reviews …, 2022 - nature.com
… prevent and/or treat chronic cardiac disease and the safety of … role of cellular senescence
in cardiac disease potentially has … information linking cellular senescence to cardiac disease, …
in cardiac disease potentially has … information linking cellular senescence to cardiac disease, …
Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies
The endothelium, a cellular monolayer lining the blood vessel wall, plays a critical role in
maintaining multiorgan health and homeostasis. Endothelial functions in health include …
maintaining multiorgan health and homeostasis. Endothelial functions in health include …
[HTML][HTML] Oxidative stress and antioxidant treatments in cardiovascular diseases
W Wang, PM Kang - Antioxidants, 2020 - mdpi.com
… as a second messenger in cellular signaling. Through targeting … Cardiovascular diseases
are the leading cause of morbidity … the progression of various cardiovascular diseases, such as …
are the leading cause of morbidity … the progression of various cardiovascular diseases, such as …
NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseases
Y Wang, X Liu, H Shi, Y Yu, Y Yu, M Li… - Clinical and …, 2020 - Wiley Online Library
… Inflammation is an important process involved in several cardiovascular diseases (CVDs),
and nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is a vital …
and nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is a vital …
Therapeutic potential of polyphenols in cardiovascular diseases: Regulation of mTOR signaling pathway
A Sanches-Silva, L Testai, SF Nabavi, M Battino… - Pharmacological …, 2020 - Elsevier
… In fact, without the identification of a specific and direct cellular target, it is very difficult to
evaluate their clinical relevance. An additional key issue regards “who does the job”, the …
evaluate their clinical relevance. An additional key issue regards “who does the job”, the …
Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases
… The complex pathobiology underlying cardiovascular diseases (CVDs) has yet to be … ,
diagnostic and prognostic biomarkers as well as drug targets in CVDs. To date, most of studies …
diagnostic and prognostic biomarkers as well as drug targets in CVDs. To date, most of studies …
[HTML][HTML] Oxidative stress in cardiovascular diseases
E Dubois-Deruy, V Peugnet, A Turkieh, F Pinet - Antioxidants, 2020 - mdpi.com
… Cardiovascular diseases comprise several disorders such as coronary artery diseases,
stroke, hypertension, heart failure, congenital heart diseases, and vascular diseases. The …
stroke, hypertension, heart failure, congenital heart diseases, and vascular diseases. The …
[HTML][HTML] Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases
L Recinella, G Orlando, C Ferrante… - Frontiers in …, 2020 - frontiersin.org
… coronary artery disease. In addition, a study conducted in 40 patients suffering from T2DM
with cardiovascular disease … with the prognosis of cardiovascular complications. In particular, …
with cardiovascular disease … with the prognosis of cardiovascular complications. In particular, …
[HTML][HTML] Extracellular vesicles in cardiovascular diseases
S Fu, Y Zhang, Y Li, L Luo, Y Zhao, Y Yao - Cell death discovery, 2020 - nature.com
… Endotheliocytes and platelets have been shown to be the major sources of EVs in patients
with stable coronary artery disease (CAD). Atherosclerotic conditions promote the packaging …
with stable coronary artery disease (CAD). Atherosclerotic conditions promote the packaging …
相关搜索
- therapeutic target cardiovascular diseases
- nlrp3 inflammasome cardiovascular diseases
- oxidative stress cardiovascular diseases
- extracellular vesicles cardiovascular diseases
- cellular senescence cardiovascular diseases
- reactive oxygen species cardiovascular diseases
- polyphenols in cardiovascular diseases
- nutraceuticals in cardiovascular diseases
- cell messengers cardiovascular diseases
- apoptosis in cardiovascular diseases
- major cardiovascular diseases
- cardiac disease basic biology
- pathogenesis and treatment of cardiovascular diseases
- cardiac disease clinical relevance
- redox roles cardiovascular diseases